European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'

M A Calderón, D Larenas, J Kleine-Tebbe, L Jacobsen, G Passalacqua, P A Eng, Eniko Varga, E Valovirta, Caroline Vilar Moreno, Hans-Jørgen Malling, E Alvarez-Cuesta, S Durham, P Demoly

94 Citationer (Scopus)

Abstract

For a century, allergen-specific immunotherapy (SIT) has proven to be an effective treatment for allergic rhinitis, asthma, and insect sting allergy. However, as allergen doses are frequently adapted to the individual patient, there are few data on dose-response relationship in SIT. Allergen products for SIT are being increasingly required to conform to regulatory requirements for human medicines, which include the need to demonstrate dose-dependent effects.
OriginalsprogEngelsk
TidsskriftAllergy
Vol/bind66
Udgave nummer10
Sider (fra-til)1345-59
Antal sider15
ISSN0105-4538
DOI
StatusUdgivet - 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy''. Sammen danner de et unikt fingeraftryk.

Citationsformater